News

In a recent webinar, Meghan Beier, PhD, MA highlights several strategies for managing the emotional impacts of ATTR-CM.

Understanding how bacteria interact with heart and digestive health could lead to more personalized treatments for patients with ATTR.

A recent study found that needing a higher dose of diuretic can serve as a useful marker for tracking disease progression.

A case report describes a 71-year old woman who was diagnosed with hereditary ATTR-CM after experiencing post-lung transplant complications.

A patient with transthyretin amyloid cardiomyopathy (ATTR-CM) benefited from early diagnosis and treatment with an oral transthyretin stabilizer, according to a case report published recently in Cureus. The 67-year-old man experienced lessening symptoms of heart failure after starting on the stabilizer. Despite worsening shortness of breath, swelling in his legs and reduced exercise tolerance, he […]

In honor of March being Amyloidosis Awareness Month, the Amyloidosis Foundation is hosting its annual Light the Night campaign.

Gene silencing and antifibril therapy could stop disease progression and eliminate amyloid deposits in patients with ATTR-CM.

A new artificial intelligence-based tool may improve quick and accurate ATTR-CM diagnosis using scintigraphy images.

Sodium-glucose cotransporter 2 inhibitors may improve clinical outcomes and health care usage in patients with ATTR-CM.

ATTR-CM is being diagnosed more frequently because of improved awareness and diagnostic tools, making it more common than previously thought.